Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies, page-10

What people don't understand is that Biotron have been working in finding these compounds that they say are effective?
But they are not the ones doing the trials, that is being done by Scripps.
Biotron could never comment about an ongoing trial that does include compounds that Biotron have found and patented for Covid and are included in these trials, it is not Biotron's call, the results will come from Scripps first, it is then and only then when Biotron can comment and not before.
The trials have been in progress now for some time, they are looking at combinations of drugs, not just one drug in particular, this was what MM talked about in the link I posted, she was talking about Hep B and HIV, but I see no reason for her to change her thinking about combinations etc and also partnering or licensing out things?
If Biotron's compounds are found to be effective in combination with other drugs and they at this point are still in there? then we are in the money I firmly believe, because it will be either licensed out to one of the larger Pharma's or they make a bid for Biotron or make them a partner in that particular anti viral combination, either way the SP would be far better than what it is now.